| Followers | 8 |
| Posts | 750 |
| Boards Moderated | 0 |
| Alias Born | 10/19/2008 |
Tuesday, May 08, 2018 12:05:44 PM
I am hoping that the good news break point will be before there is a 30 million outstanding share point considering existing, preferred and warrants. I hope they release a positive report soon on the latest evaluations. However, it is a little unrealistic to expect that soon on the latest higher dosage transplantations. I am extremely glad they made it to phase I and II human trials. The primate studies where significant and through extremely reputable entities. They showed positive efficacy, but there is nothing like being able to talk to a patient and discuss exactly how they are feeling.
Again, best of luck everywhere.
Wishing you the best of good buys,
HS
Again, best of luck everywhere.
Wishing you the best of good buys,
HS
Recent ISCO News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/30/2026 09:29:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/18/2025 10:18:02 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 09:00:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2025 01:57:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/20/2025 12:21:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2025 08:00:24 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/24/2025 08:35:04 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/24/2025 08:30:14 PM
